MGN-3 Trademark

Trademark Overview

On Tuesday, September 12, 2017, a trademark application was filed for MGN-3 with the United States Patent and Trademark Office. The USPTO has given the MGN-3 trademark a serial number of 87604294. The federal status of this trademark filing is REGISTERED as of Tuesday, September 17, 2019. This trademark is owned by Daiwa Pharmaceutical Co., Ltd.. The MGN-3 trademark is filed in the Pharmaceutical Products category with the following description:

Nutraceuticals for use as a dietary supplement containing arabinoxylan extract derived from enzymatically modified rice bran to ameliorate immune system deficiency, excluding dietary supplements for muscle growth, sports nutrition, bodybuilding, weight training or athletic training
mgn-3

General Information

Serial Number87604294
Word MarkMGN-3
Filing DateTuesday, September 12, 2017
Status700 - REGISTERED
Status DateTuesday, September 17, 2019
Registration Number5863613
Registration DateTuesday, September 17, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 23, 2019

Trademark Statements

Goods and ServicesNutraceuticals for use as a dietary supplement containing arabinoxylan extract derived from enzymatically modified rice bran to ameliorate immune system deficiency, excluding dietary supplements for muscle growth, sports nutrition, bodybuilding, weight training or athletic training

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 15, 2017
Primary Code005
First Use Anywhere DateTuesday, January 1, 2019
First Use In Commerce DateTuesday, January 1, 2019

Trademark Owner History

Party NameDaiwa Pharmaceutical Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTokyo 1540024
JP
Party NameDaiwa Pharmaceutical Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTokyo 1540024
JP
Party NameDaiwa Pharmaceutical Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTokyo 154-0024
JP

Trademark Events

Event DateEvent Description
Friday, December 22, 2017NON-FINAL ACTION E-MAILED
Friday, September 15, 2017NEW APPLICATION ENTERED
Friday, September 15, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 16, 2017ASSIGNED TO EXAMINER
Friday, December 22, 2017NON-FINAL ACTION WRITTEN
Friday, December 22, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 16, 2018TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, August 16, 2018TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, August 16, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, February 11, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, February 11, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 12, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 22, 2018FINAL REFUSAL E-MAILED
Thursday, March 22, 2018NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, March 22, 2018FINAL REFUSAL WRITTEN
Thursday, August 16, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 19, 2018LETTER OF SUSPENSION E-MAILED
Monday, November 19, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, January 17, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 16, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 16, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 19, 2018SUSPENSION LETTER WRITTEN
Monday, January 14, 2019TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, January 17, 2019ASSIGNED TO LIE
Thursday, January 17, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 14, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 3, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 23, 2019PUBLISHED FOR OPPOSITION
Tuesday, April 23, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 18, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, July 29, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 9, 2019TEAS STATEMENT OF USE RECEIVED
Tuesday, July 9, 2019USE AMENDMENT FILED
Monday, July 29, 2019STATEMENT OF USE PROCESSING COMPLETE
Wednesday, August 14, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, August 15, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 17, 2019REGISTERED-PRINCIPAL REGISTER
Thursday, August 5, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 5, 2021TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Thursday, August 5, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 5, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 17, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

dietary training muscle supplements excluding growth deficiency nutrition athletic weight